GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

It's possible that Alzheimer's disease could be added to the lengthening list of health conditions that can be improved by treatment with GLP-1 receptor ... GLP-1 agonist liraglutide in people ...

Rybelsus (semaglutide) is the first GLP-1 agonist drug that can be dosed orally, and is Novo Nordisk's third drug in the class after daily injectable Victoza (liraglutide) and weekly shot Ozempic ...

2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts ... Commercially, the most successful one so far is semaglutide, sold under the brand name Wegovy or Ozempic ...

FREEDOM-1 will compare ITCA650 in two different doses (40 and 60 µcg/day) to placebo to evaluate glycemic control in patients with uncontrolled T2D on 0–3 oral agents. The primary end point ...

such as the currently available weekly exenatide and the other weekly GLP-1 receptor agonists in development (e.g., albiglutide and dulaglutide). There seems to be a wide range of individual ...